PRISM

Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD

keywords: IMI projects Neurodegenerative diseases Psychiatric diseases Alzheimer's disease Clinical trial design Disease taxonomy Target identification Drug discovery

Project website
http://prism-project.eu/
Start date
2016-04-01
End date
2019-09-30
Types
IMI projects
Main contact
Hugh Marston
Email
-
Affiliation
Eli & Lilly
Business Address
-
Business Phone Number
-